Related Experiment Video
Updated: Aug 18, 2026
11:10
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
HLA antigens in the Guillain-Barré syndrome
1Department of Neurology United Medical School Guy's Hospital, London, U.K.
Journal of Neuroimmunology
|April 1, 1988
Abstract:
HLA typing for class I and II antigens was performed on 89 caucasoid patients with Guillain-Barré syndrome and compared with controls. No significant association, between HLA type and susceptibility to disease, prognosis at 12 months or antecedent event was discovered. HLA antigen DR2 was more frequent among patients with the most profound muscle weakness.
More Related Videos
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...